MELD score can predict early mortality in patients with rebleeding after band ligation for variceal bleeding

Table 2 Rebleeding focus, therapy and outcome of patients with rebleeding after endoscopic variceal band ligation for esophageal varices bleeding n (%)

	Overall (n = 128)
Rebleeding focus
EV bleeding	75 (58.6)
Post-EVL ulcer bleeding	24 (18.8)
GV bleeding	7 (5.5)
Peptic ulcer bleeding	11 (8.6)
PHG	11 (8.6)
Therapy for rebleeding
Endoscopic and pharmacologic therapy	92 (71.9)
Pharmacologic therapy only	35 (27.3)
Surgery	1 (0.8)
Rebleeding 5-d failure	24 (18.8)
Uncontrolled bleeding and died within 5 d	8 (6.3)
Died of non-bleeding cause	2 (1.6)
Recurrent bleeding within 5 d	14 (10.9)
5-d mortality	10 (7.8)
6-wk mortality	49 (38.3)
6-wk mortality causes
Sepsis-induced multi-organ failure	26 (53.1)
GI bleeding	18 (36.7)
Liver failure	5 (10.2)
3-mo mortality	71 (55.5)
6-mo mortality	75 (58.6)

EV: Esophageal varices; EVL: Endoscopic variceal band ligation; GV: Gastric varices; PHG: Portal hypertensive gastropathy; GI: Gastrointestinal.